Carbapenems in clinical practice: a guide to their use in serious infection
- 1 February 1999
- journal article
- guideline
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 11 (2) , 93-100
- https://doi.org/10.1016/s0924-8579(98)00094-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Beta-lactamase-mediated resistance and opportunities for its controlJournal of Antimicrobial Chemotherapy, 1998
- Prospective, randomised, multicentre study of meropenem versus imipenem/cilastatin as empiric monotherapy in severe nosocomial infectionsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1997
- Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study)Intensive Care Medicine, 1996
- Antibiotic resistance and production of extended-spectrum β-Mactamases amongst Klebsiella spp. from intensive care units in EuropeJournal of Antimicrobial Chemotherapy, 1996
- Intravenous meropenem versus imipenem/cilastatin in the treatment of serious bacterial infections in hospitalized patientsJournal of Antimicrobial Chemotherapy, 1996
- Prognosis in Intra-abdominal InfectionsArchives of Surgery, 1996
- Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unitIntensive Care Medicine, 1996
- Meropenem: a microbiological overviewJournal of Antimicrobial Chemotherapy, 1995
- Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during TherapyAnnals of Internal Medicine, 1991
- Resistance to Imipenem in Pseudomonas aeruginosa: Clinical Experience and Biochemical MechanismsClinical Infectious Diseases, 1988